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This work has focused on the synthesis of three nanosystems composed of superparamagnetic 
iron oxide nanoparticles (SPIONs) coated either with a carboxylate platinum(IV) complex 
(PD = cis,cis,trans-[Pt(NH3)2Cl2(HOOCCH2CH2COO)(OH)]) or with platinum(II) complex 
functionalized dextrans (DexPt1 = [Pt(Dex-NH2)Cl3] and DexPt2 = [Pt(Dex-NH2)(NH3)2(H2O)]). 
All nanosystems have shown superparamagnetic behavior. Powder X-ray diffraction (XRD) has 
confirmed that the SPIONs were iron oxide phase and transmission electron microscopy (TEM) 
has shown average size of 6 nm (M6). Characterization of the nanosystems by inductively coupled 
plasma atomic emission spectroscopy (ICP AES) has revealed the presence of platinum on their 
surface (M6@PD, 0.54 mmol g–1 of Fe and M6@CA@DexPt1-2, 0.32-1.20 mmol g–1 of Fe); 
infrared spectroscopy (IR) and thermogravimetric and differential thermal analyses (TG-DTA) 
have confirmed the presence of dextran. Furthermore, the colloidal properties of these nanosystems  
(M6@PD and M6@CA@DexPt1-2) have been evaluated in water and in PBS buffer. Although 
M6@PD has shown good colloidal dispersion in water in the pH range of 2.0-8.0, the system 
underwent rapid agglomeration in PBS buffer. The M6@CA@DexPt1-2 nanosystems have 
exhibited improved colloidal behavior both in water and in PBS, where hydrodynamic sizes were 
kept below 100 nm over a large pH range (2.0-12.0). Furthermore, the latter systems have displayed 
isoelectric points below pH 5.0 and low surface charges at pH 7.0 (ζ-potential = −10 mV) and 
therefore PBS did not affect their colloidal stability.
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Introduction
Superparamagnetic iron oxide nanoparticles (SPIONs) 
have been widely investigated for biomedical purposes.1 
Magnetic resonance imaging,2-4 hyperthermia5-7 and drug 
delivery8-12 are some of the practical applications displayed 
by SPIONs. These nanomaterials are promising due to the 
biocompatibility of the iron oxide cores, e.g., magnetite 
(Fe3O4) and maghemite (γ-Fe2O3).13 Furthermore, their 
surfaces can be easily modified, allowing for the tuning of 
pharmacokinetic properties.14-16
One of the key features for biomedical applications of 
SPIONs is their aqueous colloidal stability.17 Therefore, 
surface functionalization plays a relevant role on 
the balance of attractive forces, such as dispersion 
forces and dipole-dipole interactions that determine 
their agglomeration.18 Carboxylate-, phosphonate- and 
aminosilane-based derivatives have been widely used 
to coat SPIONs in order to prevent aggregation, mainly 
by electrostatic interactions due to the formation of an 
electrical double layer.16-19 However, this kind of colloidal 
dispersion is strongly affected by physiological pH and 
ionic strength.17 Coating nanoparticles with polymers, 
such as dextran (Dex) or poly(ethylene glycol) (PEG), is a 
judicious strategy to prevent SPIONs from aggregation,13,20 
diminishing opsonization and increasing circulation time.21 
These polymers can be adsorbed or chemically attached 
onto the surface of SPIONs, and because the stabilization 
of these systems is due to steric repulsions, they are less 
affected by pH and ionic strength changes than SPIONs 
modified via electrostatic interactions.17 Nonetheless the 
colloidal stability of these systems under physiological 
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conditions must be thoroughly investigated before any 
further in vitro or in vivo studies.
Coating SPIONs with dextran has led to improvement 
of their colloidal stability.18 Impregnation of cisplatin in 
the dextran-coated SPIONs has been investigated for the 
delivery of this drug to cancer cells.22 However, the drug 
could be released prematurely before reaching its target. 
Thus, the use of SPIONs coated with dextran modified with 
platinum(II) complexes may circumvent this problem. In 
this work we report the use of two new strategies (Scheme 1) 
to attach platinum complexes onto the surface of 6 nm 
SPIONs (M6): (i) by coating the SPIONs with platinum(II) 
complex functionalized dextran (DexPt1-2) and (ii) by 
direct coordination of a carboxylate platinum(IV) complex 
(PD) for comparison. Furthermore, the colloidal properties 
of these nanosystems (M6@CA@DexPt1-2 and M6@PD) 
have been evaluated in aqueous and PBS buffer media. 
These studies are essential to comprehend their behavior, 
especially with respect to aggregation and surface charge, 
which will dictate their future applications.
Experimental
Materials and methods
Carboxymethyl-dextran sodium salt (CM-Dex), citric 
acid (CA, ≥ 99.5%), N-ethyl-N’-(3-dimethylaminopropyl)
carbodiimide hydrochloride (EDC, ≥ 99%), ethylenediamine 
(EDA, ≥ 99%), hydrochloride acid (≥ 36%), hydrogen 
peroxide solution (30%), iron(II) chloride (≥ 99%), iron(III) 
nitrate (≥ 98%), nitric acid (≥ 65%), PBS buffer, potassium 
chloride (≥ 99%), potassium hydroxide (≥ 85%), potassium 
iodide (≥ 99%), potassium tetrachloroplatinate(II) (98%), 
silver nitrate (≥ 99%), succinic anhydride (≥ 99%) and all 
necessary solvents were purchased from Sigma-Aldrich. 
Ammonium hydroxide solution (25%) was purchased 
from Fluka. Iron(III) chloride aqueous solution (27%) 
was purchased from VWR International. All reagents and 
solvents were used as received.
A Bruker (USA) D8 Advance powder diffractometer by 
using the CuKα radiation (λ = 1.5418 Å) with an energy-
discriminator (Sol-X) detector was used to identify the 
crystal structure of the synthesized magnetic nanoparticles 
and the pattern were collected within 5° and 90° in 2θ. 
The core size of the nanoparticles was determined from 
transmission electron microscopy (TEM) micrographs 
using 200 keV JEOL-2000 FXII and 100 keV JEOL 
JEM1010 microscopes. The particles were dispersed in 
ethanol or water and a drop of the suspension was placed 
onto a copper grid covered by a carbon film. The average 
particle sizes and their distributions were evaluated by 
measuring the largest internal dimension of at least 100 
particles. The data were fitted to a log normal distribution 
by obtaining the mean size and the standard deviation 
(σ). A PerkinElmer (USA) OPTIMA 2100DV ICP AES 
apparatus was used to measure the concentration of iron 
and platinum in compounds after acid digestion, which 
was carried out with 0.5-1.0 mL of 12 mol L–1 HCl (for 
iron) and a mixture of 3:1 of 12 mol L–1 HCl + 15 mol L–1 
HNO3 (for platinum), added to the samples (25-50 µL), 
which were stirred for 5 min, and then, diluted to 
25-50 mL with deionized water. The infrared (IR) spectra 
were acquired in a Bruker (USA) IFS 66 V-S equipment. 
Samples were diluted in 2% potassium bromide and 
recorded between 4000 and 250 cm‑1. Simultaneous 
measurements of thermogravimetric and differential 
Scheme 1. Design of nanosystems functionalized with platinum complexes.
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thermal analyses (TG-DTA) were performed on a Seiko 
TG/DTA 320U thermobalance (Seiko Instruments) to 
determine the percentage of coating molecules on the 
surface of nanoparticles. Samples were placed in alumina 
crucibles and heated from room temperature to 900 °C at 
10 °C min–1 under an air flow of 100 mL min–1. The magnetic 
characterization of the samples was recorded in a vibrating 
sample magnetometer (MLVSM9, MagLab 9T, VSM, 
Oxford Instrument). For the measurement of powders, the 
samples were freeze-dried for 24 h in a LyoQuest freeze 
dryer (Telstar). The samples were accurately weighed and 
fitted into gelatin capsules for magnetic measurements. 
For the measurement of liquids, 100 µL of the sample 
were placed in a small piece of cotton, dried and fitted into 
gelatin capsules. The temperature was kept under 250 K. 
Hysteresis loops of the powdered samples were measured 
at room temperature and at 5 K at a rate of 5 kOe min–1.
Synthesis of platinum-based and platinum(II) complex 
functionalized dextran precursors
Cisplatin (cis-[Pt(NH3)2Cl2]),23 cis-[Pt(NH3)2I2],23 
oxoplatin (cis,cis,trans-[Pt(NH3)2Cl2(OH)2])24 and 
the  p la t inum(IV)  complex PD (cis ,cis , t rans -
[Pt(NH3)2Cl2(HOOCCH2CH2COO)(OH)])24 were 
synthesized according to the literature and their identity, 
confirmed by melting point measurements and 1H and 195Pt 
nuclear magnetic resonance (NMR) spectra.
For the synthesis of platinum(II) complex functionalized 
dextran-coated nanoparticles, CM-Dex was first chemically 
modified with 1 mol L–1 EDA (pH 4.75).25 Briefly, 160 mL 
of this solution were added to 16 g of CM-Dex and stirred. 
After adjusting the pH to 4.75, EDC (0.32 g) was added and 
once again the pH was adjusted to 4.75. The solution was 
kept under stirring for 12 h and then, purified by dialysis 
using a membrane with a 12,000-14,000 nominal molecular 
weight cut off. This procedure afforded an amino-modified 
dextran (Dex-NH2) solution with an estimated concentration 
of modified/unmodified dextran of 0.04 g mL–1, which was 
further modified with platinum derivatives as follows. A 
sample of this solution was freeze-dried for analysis that 
showed 14% of functionalized polymer molecules: anal. 
calcd. for [(C8H12O7)6(C10H18N2O6)].12H2O: C 38.71, H 
6.39, N 1.56%. Found: C 39.57, H 6.37, N 1.52%. Fourier 
transform infrared spectroscopy (FTIR) (KBr) nmax / cm–1: 
3434 (O‑H), 2924 (C‑H), 1595 (C=O),20 1280, 1156, 1016 
(C‑O) and 915, 845 (C‑C).
K[Pt(Dex-NH2)Cl3] (DexPt1)
Potassium tetrachloroplatinate(II) (0.137 g, 0.33 mmol) 
was added to 30 mL of the Dex-NH2 solution at pH ca. 7. 
The light-red solution was stirred for 72 h. This reaction 
afforded a light yellow solution, which was purified by 
dialysis, using a membrane with a 12,000-14,000 nominal 
molecular weight cut off. The estimated concentration of 
the modified/unmodified dextran polymer was 24 mg mL–1 
and the quantity of platinum complex was 71 µmol g–1 of 
dextran polymer. FTIR (KBr) nmax / cm–1: 3417 (O‑H), 
3265 (N‑H, shoulder), 2927 (C‑H), 1598 (C=O),20 1278, 
1156, 1022 (C‑O) and 916, 850 (C‑C).
[Pt(NH3)2(Dex-NH2)(H2O)](NO3)2 (DexPt2)
To cis-[Pt(NH3)2I2]  (0.484 g,  1.0 mmol) in 
dimethylformamide (DMF, 5 mL), silver nitrate (0.334 g, 
1.98 mmol) was added as a solid and the mixture was 
kept in the dark for 24 h, under stirring.26 The pale yellow 
suspension was centrifuged and the supernatant filtered 
through a 0.45 µm diameter porous filter. Evaporation of 
the solvent under vacuum yielded a dark-yellow residue of 
cis-[Pt(NH3)2(DMF)2](NO3)2. Then, 25 mL of a previously 
prepared Dex-NH2 solution at pH ca. 7 were added to 
cis-[Pt(NH3)2(DMF)2](NO3)2 and the mixture, stirred for 
72 h. Finally, the pale yellow solution was filtered and 
purified by dialysis using a membrane with a 12,000-
14,000 nominal molecular weight cut off. The estimated 
concentration of the modified/unmodified dextran polymer 
was 30 mg mL–1 and the quantity of platinum complex was 
318 µmol g–1 of dextran polymer. FTIR (KBr) nmax / cm–1: 
3434 (O‑H), 3277 (N‑H, shoulder), 2927 (C‑H), 1591 
(C=O),20 1276, 1156, 1014 (C‑O) and 913, 847 (C‑C).
Synthesis of superparamagnetic nanoparticles M6
The preparation of maghemite nanoparticles M6 was 
recently reported in the literature.17 These particles have 
been obtained in aqueous medium, following a modified 
Massart procedure.27,28 Briefly, 75 mL of a 25% NH3 
aqueous solution was rapidly added to a solution containing 
488 mL of 0.334 mol L–1 FeCl3 and 0.175 mol L–1 FeCl2, 
under vigorous stirring and at room temperature. The 
particles were isolated by magnetic decantation after 
5 min and washed three times with distilled water. They 
were then treated with HNO3/Fe(NO3)3 to fully oxidize 
magnetite (Fe3O4) to maghemite (γ-Fe2O3), which is more 
biocompatible,29 by adding 300 mL of 2 mol L–1 HNO3, 
and kept under stirring. After 15 min, the supernatant was 
completely removed and 75 mL of 1 mol L–1 Fe(NO3)3 
were added, followed by 130 mL of distilled water. The 
suspension was refluxed for 30 min and cooled to room 
temperature. The supernatant was removed, 300 mL of 
2 mol L–1 HNO3 were added and the dispersion, stirred 
for 15 min. Finally, particles were isolated by magnetic 
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decantation, washed three times with acetone, and 
redispersed in water. The acetone residue was removed 
under vacuum.
Coating of M6 nanoparticles with citric acid (M6@CA)
A slightly modified procedure was used to prepare M6 
nanoparticles coated with citric acid.19,30 After addition of 
80 mL of a 0.1 mol L–1 citric acid solution to an aqueous 
dispersion of 50 mL of M6 ([Fe] ca. 15 mg mL–1), at 
pH 3.0, the suspension was heated at 80 °C for 30 min 
under mechanical stirring. The particles were isolated 
by centrifugation and redispersed in distilled water. 
The dispersion was dialyzed using a membrane with a 
12,000-14,000 nominal molecular weight cut off. Finally, 
the pH of the M6@CA dispersion was adjusted to 7.0.
Coating of M6@CA nanoparticles with Dex-NH2 (M6@
CA@Dex)20
To a solution of 10 mL of M6@CA ([Fe] ca. 7 mg mL–1) 
at pH 7.0, under sonication, were slowly added 90 mL of a 
neutral solution of Dex-NH2 ([Dex] ca. 0.04 g mL–1). EDC 
(0.383 g) was added, the pH adjusted to 7.0 and the solution 
was stirred for 12 h. The particles were then isolated by 
centrifugation and redispersed in distilled water. Finally, the 
M6@CA@Dex particles were purified by dialysis using a 
membrane with a 50,000 nominal molecular weight cut off.
Attachment of the PD onto the surface of M6 nanoparticles 
(M6@PD)
Briefly, to a solution of 25 mL of maghemite M6 ([Fe] 
ca. 15 mg mL–1) under sonication was slowly added a 
suspension of the PD (1 mmol in 60 mL of distilled water). 
The mixture was heated for 4 h at 80 °C, under mechanical 
stirring. The particles were isolated by centrifugation and 
magnetic decantation and then, redispersed in distilled 
water and purified by dialysis using a membrane of 12,000-
14,000 nominal molecular weight cut off. Finally, the pH 
of the M6@PD dispersion was adjusted to 7.0.
Attachment of platinum(II) complex functionalized dextran 
derivatives to citrate-coated nanoparticles
General procedure: to a solution of 5 mL of 
M6@CA ([Fe] ca. 7 mg mL–1) at pH 7.0, under sonication, 
was slowly added 55 mL of a neutral solution of DexPt1 
([Dex] ca. 20 mg mL–1) or DexPt2 ([Dex] ca. 16 mg mL–1). 
The EDC (0.23 g) was added, the pH adjusted to 7.0 and the 
solution, stirred for 12 h. The particles were then isolated 
by centrifugation and redispersed in distilled water. Finally, 
the M6@CA@DexPt1 and M6@CA@DexPt2 particles 
were purified by dialysis using a membrane with a 50,000 
nominal molecular weight cut off.
Evaluation of the colloidal properties
A Zetasizer nano ZS equipment by Malvern Instruments 
was used to measure both the hydrodynamic diameter (DH, 
obtained by Z-average size values in the dynamic light 
scattering measurements) and the ζ-potential. The DH 
measurements were carried out in water and performed 
in a large range of pH values (2.0-12.0), as well as in 
the presence of PBS buffer. Furthermore, ζ-potential 
measurements were carried out using KNO3 0.01 mol L–1 as 
the background electrolyte, and the isoelectric point (IEP) 
of nanoparticles were determined after measurements in a 
large range of pH values (2.0-12.0). HNO3 and KOH were 
used to change the pH of the dispersions.
The aggregation kinetics was evaluated using a Turbiscan 
Lab apparatus by Formulation. In this equipment, a laser 
passes through the sample and the results are reported in 
transmittance (%). Thus, high transmittance values indicate 
that the sample undergoes rapid destabilization, followed by 
decantation. Measurements were performed placing 20 mL 
of the sample ([Fe] ca. 1.0 mg mL–1) in a sample holder and 
collecting data along 72 h. The experiments were carried 
out in water and in the presence of PBS buffer at pH 7.4, 
at different concentrations.
Results and Discussion
Synthesis and general characterization
The platinum(II) complex functionalized dextran 
precursors were synthesized by complexation of the 
amino-modified dextran (Dex-NH2) with K2PtCl4 
and cis-[Pt(NH3)2I2], affording K[Pt(Dex-NH2)Cl3] 
(DexPt1) and [Pt(NH3)2(Dex-NH2)(H2O)](NO3)2 (DexPt2), 
respectively. The compounds were purified by dialysis 
for 5-7 days; their identity was confirmed by FTIR 
data (see Experimental section) and the amount of 
platinum, determined by inductively coupled plasma 
atomic emission spectroscopy (ICP AES) analyses. Due 
to the low concentration of platinum in the samples the 
195Pt NMR spectra could not be obtained and 1H NMR 
spectra of Dex-NH2 and DexPt1-2 do not show appreciable 
differences.
Iron oxide nanoparticles (γ-Fe2O3, M6) were prepared 
by acid treatment of magnetite particles (Fe3O4), obtained 
by a modified Massart method.18,27,29 This procedure leads 
to the oxidation of the Fe3O4 core into γ-Fe2O3, activating 
the nanoparticles surface and thus improving their colloidal 
properties.29 The γ-Fe2O3 nanoparticles are more stable than 
Fe3O4 and have been approved by the FDA (Food and Drug 
Administration, USA) for in vivo applications.18
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According to TEM images, the M6 particles exhibit 
spherical morphology and the particle-size distribution 
curve shows diameter of 6.5 ± 0.2 nm (Figure 1). The 
identity of the iron oxide with ferrite structure was 
confirmed by X-ray diffraction (XRD) data (Figure S1) 
and indexed to an inverse spinel structure (JCPDS 34-
1346, maghemite). The average crystallite size of 6 nm was 
calculated with the Scherrer equation using full-width at 
half maximum of the (311) X-ray diffraction peak. Good 
agreement between the XRD and TEM data is observed.
Modifications on the surface of M6 nanoparticles 
with citric acid (CA) and the platinum(IV) complex 
PD (cis,cis,trans-[Pt(NH3)2Cl2(HOOCCH2CH2COO)
(OH)]) were carried out at 80 °C, affording M6@CA and 
M6@PD, respectively. No significant size changes are 
observed after this treatment according to the particle-size 
distribution curves that show mean diameters of 6.2 ± 0.3 nm 
and 5.8 ± 1.1 nm for M6@CA and M6@PD, respectively 
(Figure 1). According to TEM images, the spherical 
morphology of dextran-coated nanoparticles M6@CA@Dex, 
M6@CA@DexPt1 and M6@CA@DexPt2 is maintained 
(Figure S2).
The FTIR spectra of the maghemite nanoparticles 
before and after the functionalizations are shown in 
Figures 2 and S3. Besides the characteristic maghemite 
n(Fe−O) modes observed at 636-630, 584-578, 441-436 
and 408-396 cm–1,29 a sharp intense band at 1385 cm–1, 
assigned to N−O modes, is observed in the spectrum of M6, 
due to the presence of residual nitric acid used to oxidize 
the particles and adjust the pH (Figure S3).29 The spectra of 
M6@CA and M6@PD exhibit bands at 1258-1256 and 
1065-1040 cm–1 attributed to the vibrations of carboxylic and 
methylene groups, respectively.19 FTIR data also confirmed 
the attachment of amino-modified dextran (Dex-NH2) and 
platinum(II) complex functionalized dextran (DexPt1-2) 
precursors onto M6@CA nanoparticles, affording the 
M6@CA@Dex and M6@CA@DexPt1-2 nanosystems 
(Figures 2, S3 and S4). They show the typical amide 
group n((C=O)−NH) (1604-1598 cm–1),20 asymmetric 
CH2 (2936-2923 cm–1), carboxylic group n(C−O) (at 
around 1280, 1155 and 1015 cm–1) and α-glucopyranose 
ring deformation modes (917 and 852 cm–1) .20 All spectra 
show the n(O−H) modes at 3442-3400 and 1635-1624 cm–1 
indicating the presence of physi- and chemisorbed water 
molecules, respectively.19
Thermal analysis (TG-DTA, Figures S5-S8) reveals the 
organic content of the functionalized nanoparticles. Total 
weight loss of 13% is observed for M6@CA nanoparticles, 
whereas the M6@CA@Dex, M6@CA@DexPt1 and 
M6@CA@DexPt2 nanosystems show 77, 66 and 62% 
weight losses, respectively, in one step, starting at around 
150 °C, due to decomposition of the dextran coating.20 
These results confirm that the adopted method to attach 
dextran derivatives onto the surface of M6@CA is effective, 
affording high amounts of polymer coating.
The platinum and iron contents as well as the Pt/Fe 
ratios (mmol g–1) were determined by ICP AES. In the 
M6@PD nanomaterial, a concentration of 0.54 mmol 
of platinum per gram of iron was observed, whereas in 
Figure 1. Transmission electron micrographs of M6, M6@CA and 
M6@PD, and particle-size distributions.
Figure 2. FTIR spectra of M6@PD and M6@CA@DexPt1-2 
nanoparticles.
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the M6@CA@DexPt1 and M6@CA@DexPt2 systems, 
0.32 and 1.20 mmol of platinum complex per gram of iron 
were observed, respectively.
Evaluation of the superparamagnetic behavior
The magnetic behavior of the superparamagnetic 
nanosystems functionalized with platinum complexes 
M6@PD and M6@CA@DexPt1-2 was investigated in 
the solid state. Figure 3 shows the field dependence of the 
magnetization per mass of sample at 250 K. According to 
these data, M6@PD and the uncoated M6 nanoparticles 
exhibit almost the same saturation magnetization value 
(Msat ca. 65 emu g–1), due to the low concentration of PD 
complex attached onto the surface of the nanoparticles.22,31 
Furthermore, the diamagnetic nature of the coating 
molecules has a negligible contribution to the magnetic 
properties of the samples.18,31 However, the effect of the 
dextran coating on the magnetization of the nanoparticles is 
noticeable,18 e.g., for M6@CA@DexPt1 a decrease of 54% 
on the Msat was observed (Msat = 30 emu g–1). This result is 
related to the high amount of dextran polymer attached onto 
the surface of the M6 nanoparticles (according to TG-DTA 
data). The curves of magnetization versus temperature 
taking into account the TG-DTA results have been plotted 
(Figure S9). Thus, the magnetization data are reported 
in emu per gram of bared nanoparticles, i.e., emu per 
gram of nanoparticles without organic content. At 250 K 
the Msat values for M6, M6@PD and M6@CA@DexPt1 
are 73, 76 and 89 emu g-1. All systems share the same 
core, but the M6@PD and M6@CA@DexPt1 samples 
also contain platinum, which is not lost in the TG-DTA 
measurements.32 Therefore, a comparison of these data is 
not direct, because the quantity of platinum is relatively 
high, e.g., %Pt/Fe (m/m) are 9.5 and 5.8% for M6@PD and 
M6@CA@DexPt1, respectively. Thus, it is not possible 
to consider that the remaining mass of M6@PD and 
M6@CA@DexPt1 is composed only of iron oxide.
The magnetic data at 250 K indicate that M6@PD and 
M6@CA@DexPt1 are superparamagnetic because the 
coercivity (HC) values are zero.18 The uncoated iron oxide 
core (M6) exhibits same behavior and this is attributed 
to the small size of the nanoparticles and, even after 
several modifications on the surface, these systems remain 
superparamagnetic. At low temperature (5 K, Figure 3, 
inset), however, M6@PD and M6@CA@DexPt1 show HC 
values of 170 and 180 Oe, respectively. These similar values 
suggest that neither the nature nor the amount of coating 
material on the surface of the nanoparticles significantly 
affects the interparticle interactions or modify the surface 
layer. This result is different from previous work of our 
group18 in which we observed that functionalizations with 
distinct phosphonate- and dextran-based derivatives have 
led to lower HC and higher Msat values when compared to 
the uncoated nanoparticles.
To confirm the superparamagnetic nature of the 
nanosystems the temperature dependence of the zero-
field-cooled (ZFC) and field-cooled (FC) magnetizations 
was studied (Figure S10). According to ZFC/FC curves, 
these nanosystems show superparamagnetic behavior at 
room temperature. However, the blocking temperature 
(TB) determination for the M6@PD, M6@CA@DexPt1 
and M6@CA@DexPt2 samples is not accurate (TB 
values are between 150 and 200 K). All FC curves are 
flat below TB indicating dipolar interactions even after 
surface modification.33 Thus, the results of ZFC and FC 
curves suggest that the nanosystems exhibit large size 
distributions, as confirmed by TEM images (Figure 1).
Colloidal properties evaluation
The aqueous aggregate sizes of M6 nanoparticles were 
determined over a large range of pH values (Figure S11). 
At pH < 6.0 the nanoparticles exhibit excellent colloidal 
stability and hydrodynamic diameter (DH) below 50 nm. 
At pH 7.0, however, strong destabilization is observed and 
associated with the isoelectric point (IEP) of these particles, 
as previously determined in 0.01 mol L–1 KNO3.19 Moreover, 
same behavior was observed for the destabilization kinetics 
in water (Figure S12). At pH 7.0, M6 nanoparticles are 
unstable even in the first hour of measurement. However, 
at pH 3.0, the nanoparticles are stable.
Coating of these nanoparticles with the platinum(IV) 
complex PD to give M6@PD, with citric acid (CA)19 to 
yield M6@CA and further with amine-modified dextran 
(Dex-NH2) or platinum(II) complex functionalized dextran 
Figure 3. Field dependence of the magnetization (M) measured at 250 
and 5 K (inset) for M6, M6@PD and M6@CA@DexPt1.
da Silva et al. 737Vol. 28, No. 5, 2017
(DexPt1 or DexPt2) to yield, respectively, M6@CA@Dex 
and M6@CA@DexPt1 or M6@CA@DexPt2, resulted in 
improved stability over a large pH range (Figures 4a-4c 
and S13).
PD attachment onto the surface of M6 shifts the 
isoelectric point (IEP) to pH 8.1, giving a surface charge 
of +16 mV at pH 7.0 (Figure 4a). Despite the low 
positive surface charge on M6@PD, the system exhibits 
DH < 100 nm at pH values below 8.0, which is essential 
for biomedical applications. Attachment of Dex-NH2 and 
of DexPt1 and DexPt2 onto M6 shifts the IEP from pH 7.0 
to 2.8, 3.6 and 2.9 for M6@CA@Dex, M6@CA@DexPt1 
and M6@CA@DexPt2, respectively. These results are in 
agreement with the elemental analysis data that showed that 
only 14% of the carboxylic groups of the carboxymethyl-
dextran precursor reacted with ethylenediamine (EDA, 
Scheme 2), thus leaving many free carboxylate groups 
that are able to attach onto the surface of the nanoparticles 
and/or to establish electrostatic interactions in aqueous 
medium. Furthermore, the systems exhibit very similar 
ζ-potential values at pH 7.0, M6@CA@Dex (ζ = −14 mV), 
M6@CA@DexPt1 and M6@CA@DexPt2 (about 
ζ = −12 mV), because of the small amount of platinum 
complex present in the latter systems. In addition, these 
low negative values are associated to the stabilization of 
the systems mainly by steric repulsions, due to the high 
amount of dextran polymer attached onto the nanosystems 
(62-77%).
Therefore, the second strategy of SPIONs coating with 
platinum(II) complexes functionalized dextran yielded 
superior results, due to a combination of electrostatic 
interactions and steric repulsions, in comparison with 
direct attachment of the carboxylate platinum(IV) complex 
PD, see Scheme 1. Indeed, improved aqueous stability is 
observed for M6@CA@DexPt1 and M6@CA@DexPt2 
with DH values below 100 nm over a large pH range 
(2.0-12.0) (Figures 4b, 4c and S13).
Having confirmed the stability of the nanosystems 
in aqueous medium, their behavior in PBS buffer was 
evaluated. The M6@PD nanosystem exhibits DH of 46 nm 
at pH ca. 7 in water, but in PBS buffer aggregation takes 
place and DH increases to 172 nm (Table 1 and Figure 5). 
These results are in agreement with the destabilization 
plots (Figures 4d and S14), confirming that in PBS buffer 
rapid agglomeration occurs. Interestingly, however, the 
M6@CA@DexPt1-2 nanosystems are unaffected by PBS 
Figure 4. Hydrodynamic diameter (DH) in water and ζ-potential versus pH, in 0.01 mol L–1 KNO3 for (a) M6@PD; (b) M6@CA@DexPt1 and 
(c) M6@CA@DexPt2; (d) destabilization kinetic plots of M6 in water and M6@PD and M6@CA@DexPt1-2 in 0.01 mol L–1 PBS.
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buffer. Indeed, their DH are almost the same in water and 
in PBS buffer (Table 1 and Figure 5) and according to the 
destabilization kinetic plots (Figures 4d, S15 and S16), 
both nanosystems are stable over 72 h.
Conclusions
Beyond doubt, studies of the ionic strength and the 
presence of phosphate anions on the colloidal stability 
of nanosystems is the first step in their evaluation for 
biomedical applications. Our results show that the 
attachment of platinum drugs onto the surface of small 
SPIONs (M6@PD) without a protective coating is not 
suitable because the PBS buffer fully affects ionic strength, 
leading to agglomeration of the particles. The platinum(II) 
complex functionalized dextran-coated SPIONs 
(M6@CA@DexPt1-2) exhibit good dispersion properties 
under these conditions, without agglomeration over a large 
pH range (2.0-12.0). Furthermore, the use of different 
platinum complexes in the M6@CA@DexPt1-2 systems 
leads to similar colloidal properties.
Supplementary Information
Supplementary information (thermogravimetric 
analyses, hydrodynamic diameter versus pH destabilization 
kinetic plots in water and in PBS buffer) is available free 
of charge at http://jbcs.sbq.org.br.
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